In our latest Perspective: michelle_monje, Crystal Mackall & colleagues describe a localized toxicity syndrome associated with immunotherapy treatment for CNS tumors, and propose a new grading scale. StanfordMed CARTtherapy
1st edn .Figure 1 was designed by SciStories LLC.
Jasia Mahdi, Kara L. Davis, Robbie G. Majzner, Sneha Ramakrishna, Rebecca Richards, Liora Schultz, Crystal L. Mackall & Michelle MonjeResearch Department of Hematology and Oncology, Cancer Institute, University College London, London, UKCancer and Blood Disease Institute, Children’s Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA, USALaura M. Prolo, Michael Lim, Sonia Partap & Michelle MonjeTracy T.
Kara L. Davis, Robbie G. Majzner, Sonia Partap, Sneha Ramakrishna, Rebecca Richards, Liora Schultz, Crystal L.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Peanut allergies may be treatable with mRNA-based medicineNearly one in every fifty children suffers from peanut allergies, which can sometimes result in a fatal immune reaction.
Lire la suite »
New OC street medicine program to provide medical care for the homelessCalOptima Health is working with Healthcare in Action along with city and county officials to fund the $4 million pilot program in Garden Grove.
Lire la suite »
Discovering Inflammation’s Achilles Heel: The Breakthrough That Could Change MedicineResearchers at Kyoto University have found that neutrophils, a type of white blood cell, can induce anti-inflammatory macrophages (M2) within granulomas, which are dense globular structures that form during chronic inflammation. This M2 macrophage polarization can help regulate inflammation and tiss
Lire la suite »
Indiana Legislators Defend Teenagers from Transgender MedicineIndiana’s State Legislature approved a bill that would defend minors from transgender medical interventions, including puberty blockers, cross-sex hormone therapy, and sex change operations.
Lire la suite »
‘I’m the ’Father of Functional Medicine’—This Is My #1 Tip for Eating for Longevity’Plus an exact play-by-play of the longevity expert's recommended diet.
Lire la suite »
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results - Nature MedicineIn children, adolescents and adults with mutated ALK-driven relapsed or refractory neuroblastoma, a third-generation ALK inhibitor with or without chemotherapy was well tolerated, and recommended phase 2 doses were successfully identified in all patient groups.
Lire la suite »